Nasdaq Scheduled Resumption in CNS Pharmaceuticals Inc.

Rhea-AI Summary

The Nasdaq Stock Market (NDAQ) has announced that trading in CNS Pharmaceuticals Inc. (CNSP) will resume on May 28, 2020, at 7:00 a.m. Eastern Time. This follows a trading halt initiated on May 4, 2020, at 9:25:06 Eastern Time. The resumption of trading is significant for investors and reflects the ongoing activities of CNS Pharmaceuticals. For more details, stakeholders can look under the company's symbol on the Nasdaq website.

Positive

• Trading in CNS Pharmaceuticals will resume, providing liquidity and potential opportunities for investors.

Negative

• The trading halt indicates previous uncertainty or issues that may have affected investor confidence.

NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market^® (Nasdaq: NDAQ) announced that trading in CNS Pharmaceuticals Inc. (Nasdaq: CNSP) is scheduled to resume on Thursday, May 28, 2020, at 7:00 a.m. Eastern Time. Trading in the company’s stock was halted on May 4, 2020 at 9:25:06 Eastern Time.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotes^SM on the Nasdaq^® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

Nasdaq Media Contact:
Bianca Fata
Bianca.Fata@nasdaq.com

NDAQO

 

FAQ

When will trading in CNS Pharmaceuticals (CNSP) resume on Nasdaq?

Trading in CNS Pharmaceuticals is set to resume on May 28, 2020, at 7:00 a.m. Eastern Time.

Why was trading in CNS Pharmaceuticals (CNSP) halted?

Trading in CNS Pharmaceuticals was halted on May 4, 2020, due to unspecified concerns that necessitated a review.

What is the significance of the trading resumption for CNS Pharmaceuticals (CNSP)?

The resumption of trading allows investors to buy and sell shares, restoring market activity and liquidity.